STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
36 hedge funds and large institutions have $296M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12% more capital invested
Capital invested by funds: $264M → $296M (+$32.6M)
Holders
36
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.7M | |
| 2 | +$2.48M | |
| 3 | +$1.09M | |
| 4 |
BlackRock
New York
|
+$1.08M |
| 5 |
State Street
Boston,
Massachusetts
|
+$604K |
Top Sellers
| 1 | -$5.63M | |
| 2 | -$1.97M | |
| 3 | -$1.14M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$745K |